1 / 17

Telomerase: Cancer and the Philosopher’s Stone

Telomerase: Cancer and the Philosopher’s Stone. Sapana Vora 1 March 2007 Biology 445. Table of Contents. Chapter 1: Telomeres Chapter 2: Telomerase: Function Chapter 3: Telomerase: Structure Chapter 4: Telomerase and Cancer Epilogue Bibliography. telomere. telomere.

winola
Télécharger la présentation

Telomerase: Cancer and the Philosopher’s Stone

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Telomerase:Cancer and the Philosopher’s Stone Sapana Vora 1 March 2007 Biology 445

  2. Table of Contents • Chapter 1: Telomeres • Chapter 2: Telomerase: Function • Chapter 3: Telomerase: Structure • Chapter 4: Telomerase and Cancer • Epilogue • Bibliography

  3. telomere telomere Ch.1- Telomeres: Getting the Short End • Specialized nucleoprotein structures at chromosome ends • Repetitive arrays of guanine-rich hexameric DNA and telomere-binding proteins • Protect chromosomes from damage and degradation Human telomeric repeat sequence: 5’- TTAGGG -3’ Page 1

  4. Site of next primer Lagging strand 5’ 3’ 3’ 5’ 5’ 3’ DNA Polymerase Leading strand DNA Replication Anyone? RNA primer for Okazaki fragment Page 2

  5. Telomeres during DNA Replication • Lagging strand Okazaki fragments leave unfinished 5’ ends • No complementary strand DNA degrades Page 3 Image: http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/T/Telomeres.html

  6. Chromosomal Alzheimer’s in Action Round 1 5’ 3’ 3’ 5’ 5’ 5’ 5’ Round 30 3’ 3’ 3’ 3’ 3’ 3’ 5’ 5’ 5’ Round 60 Round 90 Page 4

  7. How Do Cells Keep from Dying? • If all cells lost telomeric DNA and thus suffered irreparable DNA damage, immortal cell lines could not exist. • But they do exist: • germline cells (including ES cells), • adult stem cells, • cancer cells Page 5

  8. Ch.2- Tying Up Loose Ends • Telomerase: • Telomerase is a reverse transcriptase that specifically synthesizes telomeric DNA • Is a type of DNA polymerase • Promotes stability of chromosomes • Protects linear DNA from degradation at chromosome ends • Is repressed in most cell types Page 6

  9. Ch.3: Of Subunits and Structure • Ribonucleoprotein (made of RNA and protein): • RNA- snoRNA-like (small nucleolar RNA) molecule called TERC (telomere RNA component) • Protein- TERT (telomere reverse transcriptase) provides catalytic action Page 7

  10. Structure and Action Page 8

  11. Ch.4- Telomerase’s Role in Cancer Page 9

  12. Telomerase Activity in Cancer Immunohistochemical localization of hTERT protein in normal and cancer cells Page 10 Shay, J. W. et al. Hum. Mol. Genet. 2001 10:677-685; doi:10.1093/hmg/10.7.677

  13. Telomerase: The Philosopher’s Stone M1 = replicative senescence (arrested proliferation with continued metabolism M2/crisis = very short telomeres and widespread apoptosis Page 11

  14. We’ve Seen This Before… Round 1 5’ 3’ 3’ 5’ 5’ 5’ 5’ Round 30 3’ 3’ 3’ 3’ 3’ 3’ 5’ 5’ 5’ Round 60 Round 90 Page 12

  15. Round 1 5’ 3’ 3’ 5’ 5’ 5’ 5’ Round 90 Round 60 Round 30 3’ 3’ 3’ 3’ 3’ 3’ 5’ 5’ 5’ Cancer Cells Do It Differently Page 13

  16. Epilogue: Cancer Therapeutics? • Telomerase is expressed almost exclusively in malignant cells… • But… • Telomere length varies in different cancer cells • ALT (alternate lengthening of telomeres) mechanisms Page 14

  17. Bibliography 1. Chen, et al. “Secondary Structure of Vertebrate Telomerase RNA.” Cell, 2000. Vol. 100 (5): 503-514 2. Counter, et al. “Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase.” Oncogene, 1998. 16: 1217-1222 3. Granger, et al. “Telomerase in cancer and aging.” Critical Reviews in Oncology/Hematology, 2002. 41 (1): 29-49 4. Hahn. “Role of Telomeres and Telomerase in the Pathogenesis of Human Cancer.” Journal of Clinical Oncology, 2003. Vol. 21 (10): 2034-2043. 5. Kimball’s Biology Pages. John W. Kimball. 23 September 2006. <http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/T/Telomeres.html> 6. Marchetti, et al. “Telomerase Activity as a Prognostic Indicator in State I Non-Small Cell Lung Cancer.” Clinical Cancer Research, 1999. 5: 2077-2081 7. Seimiya, et al. “Tankyrase 1 as a target for telomere-directed molecular cancer therapeutics.” Cancer Cell, 2005. 7:25-37. 8. Shay, et al. “Telomerase and cancer.” Human Molecular Genetics, 2001. Vol. 10 (7): 677-685 9. Stewart, et al. “Telomerase contributes to tumorigenesis by a telomere length-independent mechansim.” PNAS, 2002. Vol. 99 (20): 12606-12611

More Related